A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG

被引：37

作者：

Horwitz, MA ^{[1
]}

Harth, G ^{[1
]}

Dillon, BJ ^{[1
]}

Maslesa-Galic, S ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90095 USA

来源：

VACCINE | 2006年 / 24卷 / 10期

关键词：

BCG; bovine tuberculosis; cell-mediated immunity; protective immunity;

D O I：

10.1016/j.vaccine.2005.10.002

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Mycobacterium bovis infection of cattle and other domesticated animals exacts a significant economic toll in both economically developing and industrialized countries. Vaccination of herds and/or wild animals that share their grazing land and serve as reservoirs of infection has been proposed as a strategy to combat bovine tuberculosis. However, the only currently available vaccine, M. bovis Bacille Calmette-Guerin (BCG), is not highly efficacious. Here we show that a live recombinant vaccine, rBCG30, which expresses large amounts of the Mycobacterium tuberculosis 30kDa major secretory protein, is more efficacious against bovine tuberculosis than BCG in the highly demanding guinea pig model of pulmonary tuberculosis. Compared with the parental wild-type BCG strain, rBCG30 administered intradermally induced significantly greater cell-mediated and humoral immune responses against the 30kDa protein, as determined by measuring cutaneous delayed-type hypersensitivity and antibody titers. As for potency, in three independent experiments, rBCG30 induced greater protective immunity than BCG against aerosol challenge with a highly virulent strain of M. bovis, reducing the burden of M. bovis by 0.4 +/- 0.2 log colony-forming units (CFU) in the lung (P < 0.05) and by 1.1 +/- 0.4 log CFU in the spleen (P = 0.0005) below the level in BCG-immunized animals. A recombinant BCG vaccine overexpressing the identical M. bovis 30kDa protein, rBCG30Mb, also induced greater cell-mediated and humoral immunity against the 30 kDa protein than BCG and greater protective immunity against M. bovis challenge; however, its potency was not significantly different from rBCG30. As rBCG30 is significantly more potent than BCG against M. bovis challenge, it has potential as a vaccine against bovine tuberculosis in domesticated animals and in wild animal reservoirs. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：1593 / 1600

页数：8

共 32 条

[1]

BREIMAN RF, 1987, J EXP MED, V164, P799

[2]

Buddle BM, 1999, CLIN DIAGN LAB IMMUN, V6, P1

[3] Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle [J].

Buddle, BM ;

McCarthy, AR ;

Ryan, TJ ;

Pollock, JM ;

Vordermeier, HM ;

Hewinson, RG ;

Andersen, P ;

de Lisle, GW .

VETERINARY RECORD, 2003, 153 (20) :615-+

[4] Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection Mycobacterium bovis [J].

Chambers, MA ;

Williams, A ;

Hatch, G ;

Gavier-Widén, D ;

Hall, G ;

Huygen, K ;

Lowrie, D ;

Marsh, PD ;

Hewinson, RG .

INFECTION AND IMMUNITY, 2002, 70 (04) :2159-2165

[5] Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin [J].

Chambers, MA ;

Williams, A ;

Gavier-Widén, D ;

Whelan, A ;

Hall, G ;

Marsh, PD ;

Bloom, BR ;

Jacobs, WR ;

Hewinson, RG .

INFECTION AND IMMUNITY, 2000, 68 (12) :7094-7099

[6] Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83 [J].

Chambers, MA ;

Vordermeier, HM ;

Whelan, A ;

Commander, N ;

Tascon, R ;

Lowrie, D ;

Hewinson, RG .

CLINICAL INFECTIOUS DISEASES, 2000, 30 :S283-S287

[7]

CORPER HJ, 1926, AM REV TUBERC, V14, P662

[8] Zoonotic tuberculosis due to Mycobacterium bovis in developing countries [J].

Cosivi, O ;

Grange, JM ;

Daborn, CJ ;

Raviglione, MC ;

Fujikura, T ;

Cousins, D ;

Robinson, RA ;

Huchzermeyer, HFAK ;

de Kantor, I ;

Meslin, FX .

EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :59-70

[9] Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis [J].

de Lisle, GW ;

Wilson, T ;

Collins, DM ;

Buddle, BM .

INFECTION AND IMMUNITY, 1999, 67 (05) :2624-2626

[10] The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium [J].

de Lisle, GW ;

Wards, BJ ;

Buddle, BM ;

Collins, DM .

TUBERCULOSIS, 2005, 85 (1-2) :73-79

← 1 2 3 4 →